Latanoprost Elvim (Latanoprost)

Latanoprost binds to prostaglandin F (FP) receptors in the eye, enhancing the uveoscleral outflow pathway for aqueous humor. This increased drainage reduces the fluid volume inside the eye, thereby lowering intra‑ocular pressure.

The dosing regimen for Latanoprost Elvim is determined by the prescribing ophthalmologist. Typically, a single drop is instilled in the affected eye(s) once daily in the evening, but the exact dose and schedule must follow the clinician’s instructions.

Safety data for latanoprost in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong IOP‑lowering efficacy. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogs often achieve greater pressure reduction with a favorable dosing convenience, though individual response may vary.

Latanoprost Elvim should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from light and moisture, and keep the bottle tightly closed when not in use.

The medication is applied as an ophthalmic solution. The patient places a single drop into the prescribed eye(s) once daily, preferably in the evening, avoiding contact with the tip of the bottle and washing hands before and after use.

Serious adverse events, though rare, include severe eye inflammation (uveitis or iritis), allergic reactions with swelling or rash, sudden vision loss, and corneal ulceration. Any such symptoms require immediate medical attention.

Latanoprost Elvim is contraindicated in patients with active ocular infections, hypersensitivity to latanoprost or any component of the formulation, and should be used with caution in individuals with a history of intra‑ocular inflammation or recent ocular surgery.